Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya

Fig. 3

The predicted number of IPD cases averted by PCV10 vaccination in Kilifi with respect to the number of doses administered. In the dose-efficacy plane (a) the aggregated dose efficiency of the alternative introduction strategies within 10 years after the start of vaccination is shown. Coloured dots and lines represent medians and 95% credible intervals (the number of doses administered is fixed as taken from the health register). b shows the (incremental) number of doses needed to prevent one (additional) case of IPD. Figures for cohort vaccination alone and cohort vaccination in year 10 are presented as absolute values; the catch-up scenarios are presented as incremental values over the next smaller campaign

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us